240
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Attitude of German gynecologists towards prescribing HRT before and after the WHI study

, , , &
Pages 326-331 | Received 26 Apr 2011, Accepted 25 Sep 2011, Published online: 27 Dec 2011

References

  • Rossouw JE, Anderson GL, Prentice RL, . Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
  • Anderson GL, Limacher M, Assaf AR, . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–12
  • Hormontherapie in der Peri- und Postmenopause (HT). Downloaded on http://www.awmf.org/uploads/tx_szleitlinien/015-062_S3_Hormontherapie_in_der_Peri-_und_Postmenopause__HT__lang_09-2009_12-2011.pdf
  • Nassar AH, Abd Essamad HM, Awwad JT, . Gynecologists' attitude towards hormone therapy in the post ‘Women's Health Inititative’ study era. Maturitas 2005;52:18–25
  • Lazar FJr, Costa-Paiva L, Morias SS, . The attitude of gynecologists in Sao Paulo, Brazil 3 years after the Women's Health Initiative study. Maturitas 2007;56:129–41
  • Weissman-Brenner A, Brenner B, Sulkes J, Kaplan B. Women gynecologists’ attitude toward their own health. Med Sci Monit 2010;16:PH35–9
  • Birkhäuser MH, Reinecke I. Current trends in hormone replacement therapy: perceptions and usage. Climacteric 2008;11: 192–200
  • Bluemel JE, Castelo-Branco C, Chedraui PA, .Patients’ and clinicans’ attitudes after the Women's Health Initiative study. Menopause2004;11:57–61
  • Neyro JL, Cancelo MJ, Quereda F, . Relevance of the results of the Women's Health Initiative on the prescription of hormone therapy in Spain. Climacteric 2005;8:36–48
  • Buist DSM, Newton KM, Miglioretti DL, . Hormone therapy prescribing patterns in the United States. Obstet Gynecol 2004; 104:1042–50
  • Austin PC, Mamdani MM, Tu K, Jaakkimainen L. Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative study. JAMA 2003; 289:3241–2
  • Clanget C, Hinke V, Lange S, . Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI. Exp Clin Endocrinol Diabetes 2005;113:529–33
  • Lawton B, Rose S, McLeod D, Dowell A. Changes in the use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users. BMJ 2003; 327:845–6
  • Haas JS, Kaplan CP, Gerstenberger EP, Kerlikowske K. Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Ann Intern Med 2004;140: 184–8
  • Du Y, Doren M, Melchert HU, . Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003. BMC Women's Health 2007;7:19
  • Du Y, Scheidt-Nave C, Schaffrath Rosario A, . Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study. Climacteric 2009; 12:329–40
  • Strothmann A, Schneider HPG. Hormone therapy: the European women's perspective. Climacteric 2003;5:337–46
  • Hoffmann M, Hammar M, Kjellgren KI, . Changes in women's attitudes towards and use of hormone replacement therapy after HERS and WHI. Maturitas 2005;52:11–17
  • Heier M, Moebus S, Meisinger C, . Menopausal hormone therapy in Germany: results of three national surveys from 1997 to 2003. Maturitas 2009;62:9–15
  • Canonico M, Oger E, Plu-Bureau G, . Hormone therapy and venous thromboembolism among postmenopausal women. Impact of the route of estrogen administration and progestogens: The ESTHER Study. Circulation 2007;115: 840–5
  • Canonico M, Fournier A, Carcaillon L, . Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism. Results from the E3N Cohort Study. Arterioscler Thromb Vasc Biol 2010;30:340–5
  • Renoux C, Dell-Aniello S, Suissa S. Hormone replacement therapy and the risk of venous thromboembolism: a population-based study. J Thromb Haemost 2010;8:979–86
  • Renoux C, Dell'aniello S, Garbe D, Suissa S. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. BMJ 2010;340:c2519
  • Lokkegaard E, Andreasen AH, Jacobsen RK, . Hormone therapy and risk of myocardial infarction: a national register study. Eur Hear J 2008;29:2660–8
  • Modena MG, Sismondi P, Mueck AO, . The TREAT Collaborative Group. New evidence regarding hormone replacement therapies is urgently required. Transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005;52:1–10
  • Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: a systematic review and meta-analysis. BMJ 2008;336:1227–3
  • L'Hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol + progesterone be a safer postmenopausal HRT?. A review Maturitas 2008;60:185–201
  • Speroff L. Transdermal hormone therapy and the risk of stroke and venous thrombosis. Climacteric 2010;13:429–32
  • Birkhaeuser MH, Panay N, Archer DF, . Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008;11:108–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.